Aberdeen Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $5.81M | Buy |
47,713
+731
| +2% | +$89K | 0.02% | 441 |
|
|
2017
Q1 | $5.7M | Buy |
46,982
+7,897
| +20% | +$957K | 0.02% | 433 |
|
|
2016
Q4 | $4.78M | Sell |
39,085
-12,132
| -24% | -$1.48M | 0.02% | 448 |
|
|
2016
Q3 | $6.28M | Sell |
51,217
-279
| -0.5% | -$34.2K | 0.02% | 399 |
|
|
2016
Q2 | $6.01M | Sell |
51,496
-668
| -1% | -$78K | 0.02% | 392 |
|
|
2016
Q1 | $7.26M | Sell |
52,164
-9,676
| -16% | -$1.35M | 0.03% | 348 |
|
|
2015
Q4 | $10.3M | Buy |
61,840
+9,357
| +18% | +$1.56M | 0.04% | 288 |
|
|
2015
Q3 | $8.21M | Buy |
52,483
+1,053
| +2% | +$165K | 0.03% | 295 |
|
|
2015
Q2 | $9.3M | Sell |
51,430
-1,030
| -2% | -$186K | 0.03% | 272 |
|
|
2015
Q1 | $9.09M | Sell |
52,460
-12,298
| -19% | -$2.13M | 0.02% | 265 |
|
|
2014
Q4 | $12M | Sell |
64,758
-80,632
| -55% | -$14.9M | 0.03% | 245 |
|
|
2014
Q3 | $24.1M | Buy |
145,390
+72,318
| +99% | +$12M | 0.05% | 188 |
|
|
2014
Q2 | $11.4M | Buy |
73,072
+51,772
| +243% | +$8.09M | 0.02% | 305 |
|
|
2014
Q1 | $3.24M | Hold |
21,300
| – | – | 0.01% | 253 |
|
|
2013
Q4 | $2.81M | Hold |
21,300
| – | – | 0.01% | 258 |
|
|
2013
Q3 | $2.47M | Sell |
21,300
-300
| -1% | -$34.8K | 0.01% | 263 |
|
|
2013
Q2 | $1.99M | Buy |
+21,600
| New | +$1.99M | 0.01% | 298 |
|